Organika Health Produc ts Inc. KAVA-KAVA Liquid
Organika Health Produc ts Inc. KAVA-KAVA Liquid, NPN 80064919: natural health product licensed in Canada. Medicinal ingredients: Piper methysticum.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Piper methysticum Source : Piper methysticum - racine Potency : 30 % Kavalactones | 400 milligramme | Not calculated |
Non-medicinal ingredients
Eau purifiée, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Cuillère à thé | 1 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine as a calmative/sedative/sleep aid to promote sleep. Used in Herbal Medicine as a calmative to help relieve restlessness/nervousness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Cautions and Warnings
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you suffer from liver disease or epilepsy. Consult a health care practitioner prior to use if using conventional sedative-hypnotics (or natural health products with similar effects), anxiolytics, MAO inhibitors, and other psychopharmacological agents, levodopa (or other drugs for Parkinson's disease), or anti-platelet agents.
- Contra-Indications
Consumption with alcohol or anti-convulsants is not recommended.
- Known Adverse Reactions
Excessive use, or use with products that cause drowsiness, may impair your ability to operate vehicle or use heavy machinery. Discontinue use and consult a health care practitioner if you develop symptoms that may signal liver problems (e.g. unexplained fatigue, abdominal pain, fever, vomiting, dark urine, yellow eyes or skin). Do not use if you are pregnant or breastfeeding.
Product record
- Licence holder
- Organika Health Products Inc.
- NPN or DIN-HM
- 80064919
- Status
- Active licence
- Licence date
- 2 November 2015
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80064919
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Organika Health Produc ts Inc. KAVA-KAVA Liquid (Organika Health Products Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80064919-organika-health-produc-ts-inc-kava-kava-liquid, updated 2 November 2015.